Skip to content

Children Use Prebiotics via Digital/Day-care recruiting

Children Use Prebiotics via Digital/Day-care recruiting - CUPID

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON56893
Enrollment
120
Registered
2022-12-12
Start date
2026-03-06
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

difficulty passing stool, hard stools constipation

Interventions

Subjects will receive a can of Frutalose® OFP oligofructose or a placebo Roquette Glucidex Premium IT19 maltodextrin. Cans and scoops will look similar to ensure blinding. The scoop will be used to ad

Sponsors

Sensus B.V. (Royal Cosun)
Lead Sponsor

Eligibility

Age
No minimum to 11 Years

Inclusion criteria

Inclusion criteria: 1. Aged 1-4 years old (12 - 48 months at the day of inclusion).  2. Hard stools (score of 1 or 2 according to the mBSFS) for most (i.e. more than 50%) of the defecations in the past month, as reported by the parents.  3. Written informed consent was obtained from both parents or guardians of toddlers meeting the eligibility criteria and those willing to comply with the requirements of the study.

Exclusion criteria

Exclusion criteria: 1. Children diagnosed with functional constipation or have a history of large-diameter stools that may obstruct the toilet.  2. Children who are diagnosed with gastrointestinal (GI) disorders or known structural GI abnormalities, or previous GI surgery.  3. Children on a vegetarian/vegan diet.  4. Use of antibiotics or laxatives 4 weeks prior to the study run-in period.  5. Children on other supplements/medication that would affect bowel functioning one week prior to the study run in. This includes e.g., breast milk, fibre supplements, pre-, pro-, and synbiotics; also infant-, follow-on-, or young child formula with prebiotics, probiotics or synbiotics; alternative formula without pre-, pro-, and synbiotics will be offered.  6. Children that participate in another clinical trial.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure will be (change in) stool consistency.

Secondary

MeasureTime frame
Secondary outcomes include (change in) stool frequency and stool consistency innumber of cases (%). Tertiary outcomes include gastrointestinal symptoms, quality of life, and gut microbiome outcomes.

Countries

Netherlands

Contacts

Public ContactR.C. Havermans

Universiteit Maastricht

r.havermans@maastrichtuniversity.nl0031621877577

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 14, 2026